Objective: The objective of this study was to find out the pattern of skeletal metastasis in-patient with prostatic carcinoma by using 99m Technetium-Methylene diphosphonate ( 99m Tc MDP).
of skeletal metastases. Isotope scanning is more sensitive than radiography for detection of most skeletal metastases. Tracer accumulates in the reactive new bone that is formed in response to the lesion. Thus, although most metastatic lesions are "hot". Cold lesions are due to complete absence of reactive bone, which may represent particularly aggressive metastases. In addition, the amount of accumulation of Technetium 99m Tc-Methylene diphosphonate ( 99m Tc-MDP) tracer is sensitive to the level of blood flow. Diffuse accumulation of tracer throughout the skeleton due to disseminated skeletal disease (super scan) may lead to the false impression of a normal scan. Carcinoma prostate is the most common malignancy in males older than 50 years of age (1) . The exact incidence and distribution of cancer in Bangladesh is still undetermined due to lack of cancer registries, the importance of which in epidemiological point of view is unrecognized in our country till today (2) . In a 5 years study in Dhaka Medical College & Hospital (DMCH) shows the incidence of carcinoma of male genital system is about 2.19% among them prostate is 0.70% (3). Bone metastases are a frequent complication of cancer, occurring in up to 70% patients with advanced prostate cancer (4) . The consequences of bone metastases are often devastating. The bone scan is an important modality to evaluate skeletal pathological condition and is of utmost prognostic significance. Because of its sensitivity and the ability to examine the whole skeleton in a single examination, it still remains the most important investigation in the evaluation of skeletal metastases from prostate cancer in clinical practice. This study was focused to determine the pattern of bone secondaries in prostate
INTRODUCTION
The introduction of 99m Tc-based scan agents was started approximately 25 years ago, the radioisotope bone scan had been the standard method for detection carcinoma patients and the common sites of involvement.
PATIENTS AND METHODS
We performed a retrospective study of diagnosed prostatic adenocarcinoma patients referred to NINMAS for whole body bone scintigraphy from January 2014 to December 2014. The study included 65 subjects. Bone scan reports of all these patients were then retrospectively reviewed, and confirmation of bone metastases was determined by consideration of all available clinical information. The bone scan were performed with 99m Tc MDP as bone seeking agent, given intravenously as a dose of 18-20 mCi. Imaging was done 2-4 hours after tracer injection by a SPECT system single head Gamma Camera. Images were processed and displayed for analysis in different sections of anterior and posterior views. The subjects were divided into three groups according to their age. Sixty five patients are further subdivided into two groups according to bone scan findings i.e. 48 patients with bone metastases, termed bone scan -"positive" and 17 patients with no bone metastases, termed bone scan-"negative". Bone scan images were interpreted and the findings (areas of increased or decreased tracer localization) were recorded according to the number anatomical location, distribution (focal versus diffuse) and the shape (round, fusiform linear etc.) and reported as negative or positive for skeletal metastases.
RESULTS
The age range of 65 patients was 50 to 85 years mean ± SD was 65.80 ± 10.11 years. The subjects were divided into three groups according to their age. Findings of bone Scintigraphy in different age groups of patients is shown in Table I . The most common area of skeletal involvement was elicited by this study. According to our data the most primarily and frequently involved area were dorsal vertebrae in which 29 (60%) secondaries were seen. Sacroiliac joint was the second frequently involved area in which 19 (30%) secondaries were present followed by ribs showing 16 (33%) secondaries. Distribution of patients by site of metastasis in bone scintigraphy was shown in Table II . Patients with bone scintigraphy results were divided in four groups. Among all patients 17(27%) patients had no skeletal involvement (M0). Eighteen (28%) patients had 1-5 bony lesions and was classified M1 group. M2 group comprised 26 (40%) patients those represented presence of bony lesions in ≥ 6 sites and finally M3 group classified as presence of super scan of malignancy and was comprised 4(6%) patients. This result is shown in Table III . Well-differentiated adenocarcinoma was observed in 34 cases and shows mostly M1 group of skeletal metastasis (Figure-1) .
While moderately differentiated adenocarcinoma were found in 15 cases and correlated most with M2 metastases (Figure 2 ). Poorly differentiated adenocarcinoma were found in 16 patients and correlated with M2 and M3 groups. Other sites involved were skull, sacrum, lumbar vertebrae, ileum, mandible, femur, sternum, cervical vertebrae, iliac crest, scapula, hip joint, tibia, pelvis, ischium, pubic, knee joint and clavicle.
DISCUSSION
Metastatic prostate cancer is a leading cause of illness and death among men in the United States and Western Europe (5) . The high rate of mortality from prostate cancer may be due to late detection. Thus, prostate cancer is also a major cause of suffering and of health care expenditures (6, 7) . In this retrospective study, incidence of prostate cancer was highest (n=28, 44%) in the age group of 60 -70 years, consistent with other published literature (8, 9) . Skeletal metastases of prostate cancer was found in 48 (73%) patients that was consistent with other published literature (10) and somehow more than others Scaffer and Pollen (11, 12) . Chybowski FM and Huncharek et al., (8, 9) described about 38% of metastasis at presentation, which is consistent with this study. We found that bony lesions were were more common in axial skeleton specially in dorsal vertebra, ribs, skull , sacroiliac joint and pelvis corresponding to findings of the study by Lee et al., (13) but somehow inconsistent with Scaffer (11) . Awal et al., (14) worked with bone scintigraphy in carcinoma prostate patients in another institute about 10 years back and showed almost similar results, which prove that the pattern of distribution of skeletal metastasis remained the same. 
CONCLUSION
This retrospective study focused on the pattern of skeletal metastasis in various bony sites due to prostate carcinoma and most common sites of bony involvement were dorsal vertebra and sacroiliac joints. 
